SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing significant bullish sentiment and heightened options activity leading into its upcoming earnings call, with retail investors focused on its strong cash position, government contract wins, and accelerating commercial revenue. The community is actively debating the company's long-term quantum roadmap, potential for a short squeeze, and its perceived undervaluation compared to other players in the sector.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is trending following a series of high-profile partnerships, including a collaboration with AMD to deliver a disaggregated AI inference solution, which has sparked significant community debate over the company's valuation versus its revenue growth. Traders are actively monitoring the stock's high volatility as they weigh the long-term potential of its wafer-scale technology against concerns regarding lock-up share expirations and the sustainability of its current market cap.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is trending as investors react to a clean earnings beat and raised full-year AI revenue guidance, driven by surging demand for AI-focused networking infrastructure. While some in the community debate if the stock's massive rally has already priced in these developments, others are highlighting the company's strong backlog and strategic positioning as a long-term play in the data center buildout.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is trending as investors react to a powerful earnings report that beat revenue and EPS expectations, alongside guidance that shattered analyst estimates. The community is actively debating whether to hold through current volatility or capitalize on the company's strong AI infrastructure demand, with many viewing the dip as an opportunity to accumulate shares in a stock they believe is positioned for significant long-term growth.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as investors aggressively position themselves ahead of the upcoming earnings report, with the community closely tracking high short interest and anticipation of potential revenue growth catalysts. Traders are actively debating the impact of recent military and counter-drone contract activity while monitoring technical levels for signs of a possible short squeeze.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging as investors cheer a strong earnings report and the company's aggressive AI-focused growth strategy, triggering a massive short squeeze that has left bearish investors, including high-profile hedge fund managers, facing significant losses. The community is actively debating the sustainability of this rapid upward trajectory, with many bulls calling for continued gains toward higher price targets while others advise caution and profit-taking after the intense, volume-driven rally.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors bet on a potential take-private bid from Nelson Peltz's Trian Fund Management, with strong community sentiment focused on a possible short squeeze due to high short interest. Market participants are actively discussing buyout price expectations and the potential for a bidding war, as high volume activity drives significant attention toward the stock.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to a negative opinion from the EMA regarding its marketing authorization application in Europe, sparking community debate over the company's regulatory path and management's long-term commercial strategy. Despite this setback, many in the community remain focused on upcoming U.S. catalysts, including the active J-code billing status and potential for future revenue growth, leading to active discussion over whether the stock is undervalued.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing intense downward pressure driven by a J.P. Morgan downgrade that cited significant revenue headwinds from its China business and a challenging turnaround strategy. While the community is deeply divided between those viewing the current price as a generational buying opportunity and others labeling it a value trap destined for further declines, many investors are focused on the stock's stability around support levels and its consistent dividend yield.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

Securitize is trending as the market's first pure-play infrastructure provider for real-world asset tokenization, drawing significant attention from investors after recent analyst buy ratings and institutional accumulation from major funds. While the stock has faced volatility typical of a recent SPAC transition, the community remains focused on its long-term potential as a key player in modernizing capital markets through blockchain-based settlements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders?

Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders? Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 7, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?

SUPN vs. TEVA: Which Stock Is the Better Value Option?

New Strong Buy Stocks for August 7th

EDRY, OPBK, SUPN, MSBI and NXRT have been added to the Zacks Rank #1 (Strong Buy) List on August 7th, 2026.

Best Value Stocks to Buy for August 7th

BCAL, SUPN and NXRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 7th, 2026.

INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook

Indivior announces a merger with Supernus to form a CNS-focused biopharma company, tops Q2 earnings and revenue estimates and raises its 2026 outlook.

Why Supernus Pharmaceuticals Stock Topped the Market Today

Key PointsThe two companies will carry the Supernus name...

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) PR Newswire NEW YORK, Aug. 3, 2026 NEW YORK, Aug. 3, 2026...

Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders?

Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 3, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Shareholder Alert: Ademi LLP investigates whether Supernus Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether Supernus Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: Ademi LLP investigates whether Supernus Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders PR Newswire MILWAUKEE, Aug. 3, 2026...

SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) to Indivior Pharmaceuticals, Inc. for 1.5401 common shares of Indivior for each share of Supernus.Halper Sadeh encourages Supernus shareholders to click here to learn more about...

$SUPN Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of -$1.01 down -352.50% YoY
• Reported revenue of $219.06M up 32.40% YoY
• Supernus Pharmaceuticals is raising its full year 2026 financial guidance, now projecting total revenues in the range of $860 million to $890 million, compared to the previous $840 million to $870 million.

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.

Supernus Pharmaceuticals Inc

Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SUPNSupernus Pharmaceuticals Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest SUPN News